Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

被引:102
作者
Kumar, Ayan Tyagi [1 ]
Knops, Alexander [2 ]
Swendseid, Brian [1 ]
Martinez-Outschoom, Ubaldo [3 ]
Harshyne, Larry [4 ]
Philp, Nancy [5 ]
Rodeck, Ulrich [6 ]
Luginbuhl, Adam [1 ]
Cognetti, David [1 ]
Johnson, Jennifer [3 ]
Curry, Joseph [1 ]
机构
[1] Thomas Jefferson Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[6] Thomas Jefferson Univ, Dept Dermatol, Philadelphia, PA 19107 USA
关键词
tumor microenviroment; tumor associated macrophage (TAM); head and neck (H&N) cancer; CD68; CD163; M1; macrolphage; M2; macrophage; CD163-POSITIVE MACROPHAGES; POLARIZED MACROPHAGES; POOR-PROGNOSIS; CANCER; METASTASIS; INFILTRATION; PROGRESSION; CHEMORADIOTHERAPY; PREDICTORS; RESISTANCE;
D O I
10.3389/fonc.2019.00656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Head and neck squamous cell carcinoma (HNSCC) exists within a microenvironment rich in immune cells. Macrophages are particularly abundant in and around tumor tissue, and have been implicated in the growth, malignancy, and persistence of HNSCC (1). However, current literature reports variable degrees of association between the density of tumor-associated macrophages (TAMs) and clinicopathologic markers of disease (2, 3). These inconsistent findings may be a result of differences in approach to TAM detection. Authors have measured total TAMs in tumor tissue, while others have stained tumor samples for individual subtypes of TAMs, which include pro-inflammatory (Ml-like) and immunosuppressive (M2-like). Our aim is to more clearly define the prognostic significance of the phenotypes of tumor-associated macrophages in HNSCC. Methods: We conducted a meta-analysis of the existing publications investigating the relationship between TAMs (total and M2-like subtype) and T stage, nodal involvement, vascular invasion, lymphatic invasion, and tumor differentiation (Figure 1). A total of 12 studies were included. Forest plots and risk ratios were generated to report overall effect. Results: Higher density of both total and M2-like subtype of TAMs in the tumor microenvironment is associated with advanced T stage, increased rates of nodal positivity, presence of vascular invasion, and presence of lymphatic invasion (p < 0.0001; Figures 2-9). There is no significant association between TAM density, either total or M2-like subtype, and tumor differentiation (Figures 10, 11). Conclusions: Increased density of TAMs, including those of the M2-like phenotype, correlate with poor clinicopathologic markers in HNSCC. Our findings warrant additional investigation into the subpopulations of TAMs, the mechanisms behind their recruitment and differentiation, and the associated influence of each phenotype on tumor growth and invasion. A greater understanding of TAM dynamics in HNSCC is critical for directing further research and employing TAM-targeted adjunct therapies.
引用
收藏
页数:10
相关论文
共 71 条
[1]   Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma [J].
Adel, Mohamad ;
Kao, Huang-Kai ;
Hsu, Cheng-Lung ;
Huang, Jung-Ju ;
Lee, Li-Yu ;
Huang, Yenlin ;
Browne, Timothy ;
Tsang, Ngan-Ming ;
Chang, Yu-Liang ;
Chang, Kai-Ping .
MEDICINE, 2015, 94 (43)
[2]   Macrophages and prognosis of oral squamous cell carcinoma: A systematic review [J].
Alves, Alessandro Menna ;
Diel, Leonardo Francisco ;
Lamers, Marcelo Lazzaron .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (05) :460-467
[3]   Head and neck cancer relapse after chemoradiotherapy correlates with CD163+macrophages in primary tumour and CD11b+myeloid cells in recurrences [J].
Balermpas, P. ;
Roedel, F. ;
Liberz, R. ;
Oppermann, J. ;
Wagenblast, J. ;
Ghanaati, S. ;
Harter, P. N. ;
Mittelbronn, M. ;
Weiss, C. ;
Roedel, C. ;
Fokas, E. .
BRITISH JOURNAL OF CANCER, 2014, 111 (08) :1509-1518
[4]   CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans [J].
Beatty, Gregory L. ;
Chiorean, Elena G. ;
Fishman, Matthew P. ;
Saboury, Babak ;
Teitelbaum, Ursina R. ;
Sun, Weijing ;
Huhn, Richard D. ;
Song, Wenru ;
Li, Dongguang ;
Sharp, Leslie L. ;
Torigian, Drew A. ;
O'Dwyer, Peter J. ;
Vonderheide, Robert H. .
SCIENCE, 2011, 331 (6024) :1612-1616
[5]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[6]   Deciphering Macrophage and Monocyte Code to Stratify Human Breast Cancer Patients [J].
Bronte, Vincenzo .
CANCER CELL, 2019, 35 (04) :538-539
[7]   Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization [J].
Budczies, Jan ;
Klauschen, Frederick ;
Sinn, Bruno V. ;
Gyoerffy, Balazs ;
Schmitt, Wolfgang D. ;
Darb-Esfahani, Silvia ;
Denkert, Carsten .
PLOS ONE, 2012, 7 (12)
[8]  
Bundgaard T, 1996, HEAD NECK-J SCI SPEC, V18, P142, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<142::AID-HED6>3.3.CO
[9]  
2-L
[10]   Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy [J].
Cadoni, G. ;
Giraldi, L. ;
Petrelli, L. ;
Pandolfini, M. ;
Giuliani, M. ;
Paludetti, G. ;
Pastorino, R. ;
Leoncini, E. ;
Arzani, D. ;
Almadori, G. ;
Boccia, S. .
ACTA OTORHINOLARYNGOLOGICA ITALICA, 2017, 37 (06) :458-466